11 July 2017
READ MORE ARKEMA PA 11 PRODUCTS
Download Arkema PA 11 Brochure
DETAILS
Arkema announces a major investment plan
in its biosourced polyamide 11 chain
with a view to significantly increasing
its production capacities in Asia.
Over the next five years, the Group plans
to invest some 300 million euros in building, in Asia,
a world-scale plant dedicated
to producing PA11 biosourced polyamide from castor oil.
The new plant, which will produce both
the amino 11 monomer and its polymer, PA11,
should come on stream in late 2021.
It will enable Arkema to increase by 50%
its PA11 (powder and granule) production capacity.
With this upcoming plant, Arkema will have
a second amino 11 monomer production site,
complementing its historical site in Marseille, France.
PA11 is the only
high performance 100% biosourced polyamide
to qualify for the most exacting applications in particular
in the electronics, 3D-printing and automotive markets,
where it serves as a metal substitute.
This investment illustrates the Group’s long-term commitment
to fulfil strong demand from its customers in Asia
by offering biosourced solutions to the key challenges
of lightweighting and design of materials.
Over the next few years, annual growth of some 7%
is forecast in these markets in Asia.
With this project, the specialty polyamides business,
which already achieves 40% of its sales in Asia,
will bolster its industrial, commercial
and R&D presence in the region.
The Group thereby confirms its commitment
to support its customers by working closely
on their individual needs and providing them
with the right innovative solutions
that match the local specifics of their various markets.
This project is consistent
with the Group’s ambitious strategy
to significantly step up the development of its advanced materials,
which should eventually account for over 25% of sales,
while continuing to further consolidate its presence in Asia.
Thierry Le Hénaff,
Arkema Chairman and Chief Executive Officer
“This project represents a milestone
in the development of our specialty polyamides
over the next few years.
We send this message out to our customers
with confidence and pride. Today more than ever,
we stand by our customers to offer them
ultra high-tech biosourced product ranges.
Our aim is to support their development all around the world
with innovation-driven expert teams at their service”
INVESTOR RELATIONS CONTACTS
Sophie Fouillat
+33 1 49 00 86 37
sophie.fouillat@arkema.com
François Ruas
+33 1 49 00 72 07
francois.ruas@arkema.com
MEDIA CONTACTS
Gilles Galinier
+33 1 49 00 70 07
gilles.galinier@arkema.com
Véronique Obrecht
+33 1 49 00 88 41
veronique.obrecht@arkema.com
WWW.CHEMWINFO.COM BY KHUN PHICHAI
